Related Experiment Video
Updated: Jan 20, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
External beam radiation for HCC: Ready for incorporation into guidelines?
Michael Buckstein1, Laura A Dawson2
1Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
External beam radiation therapy is becoming an increasingly useful tool in the management of hepatocellular carcinoma at all clinical stages. The data supporting its use is now maturing, with randomised trials showing excellent results in early, intermediate, advanced, and palliative stages. This review details the current best evidence available and makes a compelling case that external beam radiation therapy should be included in clinical guidelines. Doing so will benefit patients with an effective, low cost, and globally available treatment that can dramatically improve outcomes.
Related Concept Videos
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
09:53Molecular Beam Mass Spectrometry With Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Ready Mixed Concrete
08:17Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Biological Effects of Radiation

